Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2026

Commitments and Contingencies Disclosure [Abstract]

Schedule of Liabilities Related to Legal Matters

Liabilities for legal matters were comprised of the following (in thousands):


Matter	September 30, 2026		December 31, 2025
Civil prescription opioid litigation (1)	$	9,454	$	42,271
Government investigations	8,000		—
Antitrust class action litigation	7,450		—
Other	2,630		985
Current portion of liabilities for legal matters	$	27,534	$	43,256

Civil prescription opioid litigation (Liabilities for legal matters - long term) (1)	$	71,663	$	71,819

(1)As of September 30, 2026, the total current and long-term liabilities of $81.1 million for civil prescription opioid litigation were primarily comprised of an $80.6 million liability for the Nationwide Opioids Settlement Agreement effective January 23, 2026, as defined and described in the section Civil Prescription Opioid Litigation below. Of the $80.6 million accrued for this settlement agreement, $79.7 million was for cash payments and $0.9 million was for the supply of naloxone nasal spray.

Schedule of Cash Payments

As of September 30, 2026, the remaining cash payments under the Nationwide Opioids Settlement Agreement, due on March 1 of each year, were as follows (in thousands):


	Amount Due
2027	$	12,670
2028	12,389
2029	12,389
2030	12,389
2031 (1)	11,939
2032 to 2034 (1)	35,816
Total settlement payments	$	97,592
Less: imputed interest at a rate of 5.5%	(17,917)
Total	$	79,675

(1)Amounts due in each of 2031 through 2034 include approximately $10.4 million of cash conversion payments associated with certain settling parties’ elections to receive cash in lieu of naloxone nasal spray under the Nationwide Opioids Settlement Agreement ($41.4 million in the aggregate).